AstraZeneca AB
AstraZeneca AB, a leading global biopharmaceutical company, is headquartered in Sweden (SE) and operates extensively across Europe, North America, and Asia. Founded in 1999 through the merger of Astra AB and Zeneca Group, the company has since established itself as a key player in the pharmaceutical industry, focusing on innovative medicines in areas such as oncology, cardiovascular, renal, and respiratory diseases. AstraZeneca is renowned for its commitment to research and development, with a robust pipeline of unique therapies that address unmet medical needs. Notable achievements include the rapid development of its COVID-19 vaccine, which showcased the company's agility and dedication to public health. With a strong market position, AstraZeneca continues to drive advancements in healthcare, making significant contributions to patient outcomes worldwide.
DitchCarbon Score
How does AstraZeneca AB's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
AstraZeneca AB's score of 100 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
AstraZeneca AB, headquartered in Sweden (SE), currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of AstraZeneca PLC, which cascades its emissions data and climate commitments down to its subsidiaries. AstraZeneca PLC has made significant commitments to reduce its carbon footprint, including initiatives aligned with the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). However, specific reduction targets or achievements for AstraZeneca AB are not detailed in the available data. The company is also involved in the RE100 initiative, aiming for 100% renewable electricity, and the Race to Zero campaign, which focuses on achieving net-zero emissions. These commitments reflect AstraZeneca's dedication to addressing climate change and reducing its environmental impact, although specific metrics for AstraZeneca AB remain unspecified. As a subsidiary, AstraZeneca AB's climate strategies and performance are influenced by the overarching goals set by AstraZeneca PLC, which operates at a higher corporate level.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 298,498,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 322,319,000 | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
AstraZeneca AB is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
